Allianz's pricey valuation and limited EPS upside justify a neutral rating. Balance sheet strength is noted, but buyback ...

M, consensus $627.1M. Sees FY25 gross margin 55%-56%. The company said, “This guidance is expressed in good faith and is based on management’s current view of anticipated results on a pro forma basis.

Backs FY25 revenue view at least $385.9B, consensus $388.85B. Backs FY25 free cash flow view $6.5B. Backs FY25 capital expenditures view ...

Research analysts at Roth Capital raised their Q1 2025 earnings per share (EPS) estimates for shares of Stardust Power in a ...

Investment analysts at Roth Capital lifted their Q1 2025 EPS estimates for shares of Contango Ore in a report issued on ...

Youpa Stein writes, The presence of unbound styrene in the containers, the ability of this styrene to contaminate food, and ...

Rocket Companies, Inc., provides spanning mortgage, real estate, and personal finance services in the United States and Canada. It operates through two segments, Direct to Consumer and Partner ...

Relmada Therapeutics Inc. reported its fourth-quarter 2024 earnings, showing a net loss per share of $0.62, an improvement from the previous year’s $0.84 loss per share. The company’s stock responded ...

The net sales missed the consensus mark but grew on a year-over-year basis. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. The quarter’s results were driven by strong ...